Uterine fibroids (also known as leiomyomas or myomas) are common clonal neoplasms of
the uterus. Fibroids have both smooth muscle and fibroblast components, in addition to a …

Introduction Up to one-third of women of reproductive age experience heavy menstrual
bleeding (HMB). HMB can give rise to iron deficiency (ID) and, in severe cases, iron …

Background Uterine fibroids are a common cause of heavy menstrual bleeding and pain.
Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone …

Background Uterine fibroids occur in up to 40% of women aged over 35 years. Some are
asymptomatic, but up to 50% cause symptoms that warrant therapy. Symptoms include …

Hysterectomy is the most common treatment option in women with uterine fibroids, providing
definitive relief from the associated burdensome symptoms. As with all surgical …

Myomectomy can increase the rate of pregnancy in women with infertility, attempting to
restore a normal anatomy and reduce uterine contractility and local inflammation associated …

Key Clinical Points Uterine Fibroids Uterine fibroids are common in women of reproductive
age; they are particularly prevalent among black women and are more often associated with …

Background: Uterine fibroids are common, benign, smooth-muscle tumors that can cause
major morbidity for reproductive-age women, often requiring invasive treatment. Despite this …

An oral fixed-dose combination of relugolix/estradiol/norethisterone (also known as
norethindrone) acetate (Ryeqo®; Myfembree®) has been approved for the management of …

Background: Uterine leiomyomas (fibroids) are the most common benign pelvic tumors in
women of reproductive age with an incidence ranging from 5.4% to 77%, Also, there is a …